OCDX News and Press, Ortho Clinical Diagnostics plc From 04/20/22

RARITAN, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will report results for its first quarter 2022 ended April 3, 2022, after the market close...

Quidel recorded its best-ever revenue performance in 2021 at $1.699 billion despite its gross profit falling to $1.271 billion YOY. The fairly priced QuickVue At-Home OTC gave Quidel the impetus to enter retail and the home Covid-19 testing market. Reimbursement policies by third-...

Berkshire Hathaway to acquire all outstanding Alleghany shares for $848.02 per share in cash, for a total equity value of approximately $11.6 billion. This is one of the five largest acquisitions in Berkshire's history and it ends Buffett's six-year drought of large acquisitions. ...

RARITAN, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been awarded a Bronze 2022 Stevie ® Award for Sales and Customer Service Department of the Year. The award...

Ortho Clinical Diagnostics went public in January 2021, raising $1.3 billion in gross proceeds in an IPO. The firm provides diagnostics services primarily to hospital labs in the U.S. With the acquisition deal potentially on approval hold and Quidel’s sharp stock price drop...

Intel to acquire Tower Semiconductor for $53 a share, representing a premium of almost 60% to Tower's closing price the previous day. Madison Dearborn Partners to acquire MoneyGram International for $11 per share, representing a premium of approximately 50% to MoneyGram’s unaff...

The following slide deck was published by Ortho Clinical Diagnostics Holdings plc in conjunction with their 2022 Q4 earnings call. For further details see: Ortho Clinical Diagnostics Holdings plc 2022 Q4 - Results - Earnings Call Presentation

Ortho Clinical Diagnostics Holdings PLC (OCDX) Q4 2021 Earnings Conference Call February 16, 2022, 17:00 ET Company Participants Bryan Brokmeier - VP, IR Christopher Smith - Chairman & CEO Joseph Busky - CFO Michael Iskra - EVP, Commercial Excellence & Strategy Conference Call Partici...

Image source: The Motley Fool. Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) Q4 2021 Earnings Call Feb 16, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Ortho Clinical Diagnostics Holdings plc (OCDX) Q4 2...

Ortho Clinical Diagnostics press release (NASDAQ:OCDX): Q4 Non-GAAP EPS of $0.18 beats by $0.03. Revenue of $521M (+0.9% Y/Y) misses by $4.26M. For further details see: Ortho Clinical Diagnostics Non-GAAP EPS of $0.18 beats by $0.03, revenue of $521M misses by $4.26M